Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-062530

General Counsel acquired 32,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
O'Brien Patrick General Counsel 2022-12-21 Option exercise +32,000 $6.15 $196,800 380,875 D
Derivatives
O'Brien Patrick General Counsel 2022-12-21 Option exercise · Stock Option (right to buy Common Stock) −32,000 0 D
Loading xslF345X03/doc4.xml…